Does Bartter Syndrome Cause Hypercalciuria?
Yes, Bartter syndrome typically causes increased urinary calcium excretion (hypercalciuria), though this varies by genetic subtype.
Pathophysiology
The hypercalciuria in Bartter syndrome results directly from the primary defect: impaired salt reabsorption in the thick ascending limb of Henle's loop leads to reduced calcium reabsorption, causing calcium wasting in the urine 1. This mechanism is consistent across most subtypes and represents a fundamental consequence of the underlying tubular transport defect.
Subtype-Specific Calcium Excretion Patterns
The presence and severity of hypercalciuria follows a clear genotype-phenotype correlation 1:
High Calcium Excretion:
- Type 1 (SLC12A1/NKCC2): High urinary calcium
- Type 2 (KCNJ1/ROMK): High urinary calcium
- Type 4a (BSND/Barttin): Variable calcium excretion
- Type 4b (CLCNKA + CLCNKB): High calcium excretion
- Type 5 (MAGED2): Variable calcium excretion
Exception - Type 3:
Type 3 (CLCNKB/ClC-Kb) represents the notable exception, with most patients having a milder defect without hypercalciuria and partial capacity to concentrate urine 1. This subtype can be virtually indistinguishable from Gitelman syndrome, which characteristically presents with hypocalciuria rather than hypercalciuria.
Clinical Significance
Hypercalciuria in Bartter syndrome frequently leads to nephrocalcinosis, particularly in types 1,2, and 4b 1, 2. The rate of nephrocalcinosis is substantially higher in type 2 (100%) compared to type 4 (16%) 3, reflecting the severity and chronicity of calcium wasting.
Associated Metabolic Abnormalities:
Type 2 Bartter syndrome demonstrates particularly severe calcium-related complications 3:
- Markedly elevated PTH levels (average 160.6 pg/ml vs. 92.5 pg/ml in type 4)
- Evidence of PTH resistance
- Higher urinary calcium/creatinine ratios
- Universal nephrocalcinosis
Some patients develop secondary hyperparathyroidism in response to chronic hypercalciuria 3, 2. Rarely, patients may present with hypercalcemic hyperparathyroidism as an atypical manifestation 2.
Mechanism of Vitamin D Involvement
The hypercalciuria may be exacerbated by elevated 1,25-dihydroxyvitamin D levels, creating an absorptive hypercalciuria pattern 4. Treatment with indomethacin (a prostaglandin synthesis inhibitor) reduces both 1,25-dihydroxyvitamin D levels and urinary calcium excretion, suggesting prostaglandin-mediated vitamin D dysregulation contributes to the calcium wasting.
Clinical Pitfall
Do not assume all electrolyte abnormalities in Bartter syndrome follow the classic pattern. While hypercalciuria is typical, rare presentations include hypocalcemia as the initial manifestation 5, particularly when complicated by vitamin D deficiency. In such cases, whole exome sequencing may be necessary to establish the diagnosis when clinical presentation is atypical.